Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pozen sues, saying patent infringed
Bizjournals.com
Wednesday, June 1, 2011 - 7:48am
tags:
Pozen, patents, GSK, migraines, Sun Pharma, Treximet
Positive Data for UCB's Cimzia
Yahoo/Zacks.com
Wednesday, June 1, 2011 - 7:47am
tags:
UCB Pharmaceuticals, Cimzia, Abbott Laboratories, rheumatoid arthritis
Drugmakers Face Patent Cliff Generics
Yahoo/InvestorsBusinessDaily
Wednesday, June 1, 2011 - 7:46am
tags:
patents, generics, GSK, Bristol-Myers Squibb, AstraZeneca, Pfizer, Eli Lilly, Merck, Forest Labs, Teva Pharmaceuticals, Abbott Laboratories
N. American pharma buys drive up M&A prices
Fierce Pharma
Tuesday, May 31, 2011 - 6:01pm
tags:
M&A
6 Prime Biotechs for Short- and Long-Term Gains
Seeking Alpha
Tuesday, May 31, 2011 - 5:59pm
tags:
BioSante, Supergen, Acadia, Rexahn, Aeterna Zentaris, Antares
Teva Settles Neurontin Case With Pfizer on Undisclosed Terms
Bloomberg
Tuesday, May 31, 2011 - 5:57pm
tags:
Pfizer, Teva Pharmaceuticals, settlements, Neurontin
Bacterin International: A Biotech Heading Toward Profitability
Seeking Alpha
Tuesday, May 31, 2011 - 1:56pm
tags:
Bacterin International Holdings
Sanofi's diabetes drug cuts blood sugar, weight-study
Reuters
Tuesday, May 31, 2011 - 1:54pm
tags:
Sanofi, diabetes, Lyxumia
Amarin taps suppliers for 'aggressive' launch
Fierce Pharma
Tuesday, May 31, 2011 - 1:52pm
tags:
AMR101, Amarin, GSK, Lovaza
Aegerion Pharma posts new lomitapide study data
Yahoo/AP
Tuesday, May 31, 2011 - 1:46pm
tags:
lomitapide, Aegerion, cholesterol
Affymax, Takeda seek approval of peginesatide in dialysis patients with chronic kidney disease
Yahoo/AP
Tuesday, May 31, 2011 - 12:39pm
tags:
chronic kidney disease, Takeda, Hematide/peginesatide, Affymax
Optimer Prices New Antibiotic at Premium
TheStreet.com
Tuesday, May 31, 2011 - 12:37pm
tags:
Optimer, antibiotics, drug pricing, Dificid, Clostridium Difficile
The Biggest Gift Biotechs Can Give to Investors
Motley Fool
Tuesday, May 31, 2011 - 12:36pm
tags:
investors, biotech, Vertex Pharmaceuticals, Exelixis, CytRx, GSK, Novavax, JNJ, Pfizer, Biogen Idec, Seattle Genetics, Immunogen, Alnylam
7 Dividend Winners in Big Pharma
Seeking Alpha
Tuesday, May 31, 2011 - 10:56am
tags:
Abbott Laboratories, AstraZeneca, GSK, dividends, JNJ, Merck, Novartis, Pfizer
Five Lessons From Niaspan’s Disappointing Study
Forbes
Tuesday, May 31, 2011 - 9:40am
tags:
Niaspan, Abbott Laboratories
Teaching Med Students About Industry Influence
Pharmalot
Tuesday, May 31, 2011 - 9:39am
tags:
med students, drug reps, physicians, physician gifts
Optimer climbs in pre-market trading and company readies launch of first FDA-approved drug
Yahoo/AP
Tuesday, May 31, 2011 - 9:22am
tags:
FDA, Optimer, antibiotics, Clostridium Difficile, Dificid
J&J May Build Plant or Distribution Center in Brazil, Globo Says
Bloomberg
Tuesday, May 31, 2011 - 9:19am
tags:
JNJ, Brazil
A Rare Opportunity in Abbott Labs
Seeking Alpha
Tuesday, May 31, 2011 - 9:18am
tags:
Abbott Laboratories
Is Affymetrix's Stock a Bargain by the Numbers?
Motley Fool
Monday, May 30, 2011 - 6:40pm
tags:
Affymetrix

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.